Stocks · Korea
014570
KOSDAQ
Korean Drug
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER5.33x
PBR0.42x
EPS602 KRW
BPS7,678 KRW
ROE8.40%
Dividend yield5.61%
DPS180 KRW
Payout ratio29.90%
Returns and 52-week range
1W-2.28%
1M-8.29%
3M-4.75%
6M-19.55%
1Y-30.67%
YTD-25.69%
52W high4,585원
52W low3,060원
From 52W high-29.99%
Financial results (separate)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 800억 | 143억 | 118억 | 17.9% |
| 2023 | 814억 | 180억 | -49억 | 22.1% |
| 2024 | 730억 | 91억 | 30억 | 12.5% |
| 2025 | 625억 | 69억 | 65억 | 11.1% |
| Quarterly | ||||
| 2024 4Q | 177억 | -25억 | -19억 | -14.0% |
| 2025 1Q | 131억 | 8억 | 8억 | 6.2% |
| 2025 2Q | 149억 | 22억 | 20억 | 15.0% |
| 2025 3Q | 165억 | 20억 | 19억 | 12.0% |
| 2025 4Q | 180억 | 19억 | 18억 | 10.5% |
| 2026 1Q | 133억 | 12억 | 12억 | 8.8% |
Company
Address: 경기도 이천시 신둔면 원적로 69-10
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-18주요사항보고서(자기주식처분결정) Major
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.